Simplex Trading
TMCI icon

Simplex Trading’s Treace Medical Concepts TMCI Stock Holding History

Simplex Trading’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,900
Closed -$144K – 10163
2025
Q4 		$144K Buy
+58,900
New +$256K ﹤0.01% 4583
2025
Q1 		– Sell
-500
Closed -$3K – 9688
2024
Q4 		$3K Sell
500
-121,700
-100% -$814K ﹤0.01% 7935
2024
Q3 		$708K Buy
122,200
+700
+0.6% +$4.5K ﹤0.01% 3243
2024
Q2 		$807K Buy
121,500
+56,800
+88% +$459K ﹤0.01% 3141
2024
Q1 		$844K Buy
64,700
+3,000
+5% +$40K ﹤0.01% 3298
2023
Q4 		$786K Buy
61,700
+56,000
+982% +$566K ﹤0.01% 3253
2023
Q3 		$74K Buy
5,700
+5,400
+1,800% +$98.8K ﹤0.01% 5415
2023
Q2 		$7K Sell
300
-600
-67% -$15.5K ﹤0.01% 7724
2023
Q1 		$22K Buy
+900
New +$21.1K ﹤0.01% 6833
2022
Q2 		– Sell
-500
Closed -$9K – 11101
2022
Q1 		$9K Buy
+500
New +$9.72K ﹤0.01% 8982

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TMCI Position: Q1 2026 in Review

Simplex Trading sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 25,929 shares — an estimated $51.7K sold.

Simplex Trading first reported a position in TMCI in Q2 2023 and held it in 8 quarters. The position peaked at $858K in Q4 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Simplex Trading reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 25,929 Treace Medical Concepts shares in Q1 2026, an estimated $51.7K.
  • Simplex Trading first reported a position in Treace Medical Concepts in Q2 2023 and held it in 8 quarters.
  • Simplex Trading's Treace Medical Concepts position peaked at $858K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.